Tag: johnson & johnson
Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data
Another COVID-19 vaccine is almost ready to begin being distributed – a single-shot inoculation made by Johnson & Johnson’s Janssen pharmaceutical subsidiary. The company just released an efficacy report based on data from its Phase 3 trial, which found that the new vaccine is 66% effective overall in preventing moderate…
Read More
Moderna set to start final-stage trial of its coronavirus vaccine by July
Pharmaceutical company Moderna told Bloomberg on Thursday that it’s on pace to begin the final-stage clinical trial of its vaccine for the novel coronavirus that causes COVID-19 by July. Moderna was the first company to begin human clinical trials of its vaccine candidate in the U.S., and the last stage…
Read More
Cue Health raises $100 million to speed development of rapid, portable COVID-19 diagnostics
San Diego-based startup Cue Health has closed a $100 million Series C funding round, including participation from Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation, ACME Capital and others. The funding will be used to help Cue finish up development, validate and scale production of its Cue…
Read More
Workforce training app developer Poka adds strategic investor Schneider Electric
Poka, a workforce training app and software service for industrial companies, has added SE Ventures, the venture capital arm of the European energy and automation conglomerate Schneider Electric to its roster of backers. The company has raised over $23 million in funding so far for its application and software services…
Read More
Locatee raises $4M Series A for its workplace analytics platform
Locatee, a Swiss startup that uses existing sensors and IT infrastructures to provide employers and commercial real estate owners with detailed data about how their spaces are utilized, today announced that it has raised a $4 million Series A funding round led by San Francisco-based FYRFLY Venture Partners and Zurich-based…
Read More
Johnson & Johnson partners with BARDA to fund $1 billion in COVID-19 vaccine research
Pharmaceutical giant Johnson & Johnson is partnering with the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services to fund over $1 billion in COVID-19 vaccine and antiviral treatment research and development, the company said on Monday. The partnership is an expansion of an…
Read More